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ABSTRACT Entry into cells is critical for virulence of the human bacterial pathogens Shigella spp. Shigella spp. induce membrane
ruffle formation andmacropinocytic uptake, but the events instigating this process are incompletely understood. The host small
GTPase ADP-ribosylation factor 6 (ARF6) functions in membrane trafficking at the plasmamembrane and activates membrane
ruffle formation. We demonstrate that ARF6 is required for efficient Shigella flexneri entry, is activated by S. flexneri dependent
on the phosphatase activity of the type III secreted effector IpgD, and depends on cytohesin guanine nucleotide exchange factors
(GEFs) for recruitment to entry sites. The cytohesin GEF ARF nucleotide binding site opener (ARNO) is recruited to these sites,
also dependent on IpgD phosphatase activity. ARNO recruitment is independent of ARF6, indicating that, in addition to the de-
scribed recruitment of ARNO by ARF6, ARNO is recruited upstream of ARF6. Our data provide evidence that ARF6, IpgD, phos-
phoinositide species, and ARNO constitute a previously undescribed positive feedback loop that amplifies ARF6 activation at
bacterial entry sites, thereby promoting efficient S. flexneri uptake.
IMPORTANCE Shigella spp. cause diarrhea and dysentery by infection of epithelial cells in the human colon. Critical to disease is
the ability of Shigella to enter into cells, yet the mechanisms involved in entry are incompletely understood.We demonstrate
that the small GTPase ADP-ribosylation factor 6 (ARF6) is required for efficient cellular entry of Shigella flexneri and that acti-
vation of ARF6 depends on the phosphatase activity of the Shigella protein IpgD, which is introduced into cells via the bacterial
type III secretion system.We further show that IpgD phosphatase activity is required for recruitment of the ARF6 guanine nu-
cleotide exchange factor (GEF) ARF nucleotide binding site opener (ARNO) to bacterial entry sites and that ARNO lies upstream
of ARF6 activation. These relationships define a positive feedback loop that contributes to activation of ARF6 at S. flexneri entry
sites and leads to local amplification of signals that promote bacterial entry.
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Shigella spp. are Gram-negative bacterial pathogens that causediarrheal disease by invading and spreading through the co-
lonic epithelium. Shigella entry into intestinal epithelial cells is
critical to the disease process (1, 2) and requires a type III secretion
system (T3SS) and secreted effectors (2, 3). Upon contact with
nonphagocytic cells, delivery of T3SS effector proteins causes re-
arrangements of the actin cytoskeleton, which induce plasma
membrane ruffling that leads to macropinocytic uptake of the
pathogen (4).
Several bacterial and host proteins have been shown to be in-
volved in Shigella entry. Disruption of the activity of individual
proteins leads to defects but not to complete abrogation of entry,
indicating that entry pathways are partially redundant. Shigella
IpaA promotes entry by binding vinculin, but an ipaAmutant still
invades at low frequency (5). Actin rearrangements promoted by
the small Rho GTPases Cdc42 and Rac1 contribute to entry, yet
expression of dominant negative forms of either decreases entry
by only ~70% (6). Activation of the Rac1 guanine exchange factor
(GEF) DOCK180/ELMO by Shigella IpgB1 contributes to entry,
yet an ipgB1 mutant invades at 35% of the efficiency of the wild
type (WT) (7, 8).
GTPases are molecular switches that transduce signals to reg-
ulate functions as diverse as gene expression, vesicular trafficking,
and cytoskeletal rearrangement (9) and are manipulated by sev-
eral bacterial pathogens (10). GTPases of the ADP-ribosylation
factor (ARF) family act at the plasma membrane and at endo-
somes to regulate membrane trafficking, phosphoinositide and
lipid metabolism, and actin remodeling (11, 12). Distinct from
other ARF GTPases in amino acid sequence and intracellular
localization, GTP-bound ARF6 is localized to the plasma mem-
brane and on endosomes, where it activates phosphatidylinositol
4-phosphate 5-kinase (PIP5K), generating phosphatidylinositol
4,5-bisphosphate [PI(4,5)P2] (13–15). In motile cells, ARF6 also
promotes actin remodeling via activation of Rac1, dependent on
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the GEFs ARF nucleotide binding site opener (ARNO) and
DOCK180/ELMO complex (16–19).
The localization of ARF6 at the plasma membrane and its
role in membrane trafficking and actin remodeling during en-
docytosis place it in an ideal position to participate in pathogen
uptake and endosome remodeling (18–22). The mechanism of
ARF6 recruitment and activation has not been described for
any pathogen.
We report a role for ARF6 in a previously undescribed positive
feedback loop that amplifies ARF6 activation to promote Shi-
gella flexneri entry. We find that ARF6 is activated during S. flex-
neri entry and is required for efficient entry.We show that theARF
GEF ARNO lies upstream of ARF6 in this pathway and that the
activity of the T3SS effector IpgD, an inositol 4-phosphatase (23–
25), is required for recruitment of both ARF6 and ARNO to bac-
terial entry sites. These findings provide new insights into the
mechanism of GTPase recruitment and activation during bacte-
rial entry.
RESULTS
ARF6 is required for efficient entry of S. flexneri.To test whether
ARF6 contributes to S. flexneri infection, we quantified the effi-
ciency of infection in HeLa cells transfected with wild-type (WT)
hemagglutinin (HA)-tagged ARF6 or ARF6 N122I, a dominant
negativemutant unable to bind guanine nucleotides (21). At 2 h of
infection, the number of intracellular bacteria in cells expressing
ARF6 N122I was 30% less than in cells expressing WT ARF6
(7.2  0.1 versus 5.1  0.2 intracellular bacteria per transfected
cell, P  0.001) (Fig. 1A), demonstrating that entry and/or early
intracellular replication of S. flexneri is less efficient in the presence
of dominant negative ARF6. To test whether ARF6 per se is re-
quired for efficient infection, we examined infection in mouse
embryonic fibroblasts (MEFs) that harbor a stable lentiviral short
hairpin RNA (shRNA) construct targetingArf6mRNA (ARF6K/D)
(26), such that levels of ARF6 are reduced by90% compared to
control cells (ARF6) that harbor a nontargeting lentiviral inser-
tion (see Fig. S1A in the supplemental material). Viable intracel-
lular S. flexneri levels in ARF6K/D MEFs were 2-fold decreased
compared to ARF6MEFs at 1 and 2 h of infection (at 1 h, 1,327
311 CFU versus 651  147 CFU, P  0.03; at 2 h, 11,027 
1,430 CFU versus 5,188 193 CFU, P 0.03) (Fig. 1B). Thus, in
both HeLa cells and MEFs, in the absence of ARF6, entry and/or
early intracellular replication of S. flexneri is less efficient.
S. flexneri entry into cells occurs as early as 15 min after bacte-
rial contact with the host cell (27, 28). To test whether ARF6 is
required for S. flexneri entry per se, we quantified the percentage of
intracellular bacteria 40 min after initial contact with cells, before
significant replication of intracellular bacteria would have oc-
curred, differentiating extracellular bacteria from those that were
intracellular by differential labeling. Extracellular bacteria were
identified by labeling with S. flexneri lipopolysaccharide (LPS)
prior to cell permeabilization, whereas all bacteria were identified
by staining DNAwith 4=,6-diamidino-2-phenylindole (DAPI). At
40 min of infection, the number of cells infected by S. flexneri was
decreased by 75% in ARF6K/D MEFs compared to ARF6 MEFs
(32% 8.6% versus 8% 0.6% of cells were infected, P 0.03)
(Fig. 1C and D, left graph). When transiently transfected with an
HA-tagged WT ARF6 construct, ARF6K/D MEFs exhibited partial
restoration of ARF6 protein levels (see Fig. S1A in the supplemen-
talmaterial). The relativelyminor rescue in levels was likely due to
the combination of only a portion of the cells having been trans-
fected and the susceptibility of the ARF6-HA RNA to the shRNA
expressed in the ARF6K/D cells. Nevertheless, transient transfec-
tion of this construct resulted in rescue of bacterial entry to that in
ARF6MEFs (Fig. 1D, right graph), suggesting that relatively low
levels of ARF6 are sufficient to promote entry and demonstrating
that efficient S. flexneri entry is dependent on ARF6.
Virulent S. flexneri activates ARF6 during early infection.
Like most small GTPases, in resting cells, ARF6 is predominantly
in the GDP-bound inactive form. The requirement for ARF6 for
efficient S. flexneri entry suggested that ARF6 might be activated
during this process. To quantify ARF6 activation, GTP-bound
FIG 1 ARF6 is required for efficient entry of S. flexneri. (A) Efficiency of
infection of HeLa cells transfected with ARF6-HA or dominant negative ARF6
N122I-HA. Number of intracellular bacteria per cell at 2 h of infection, by
differential staining. (B) S. flexneri recovered after infection (1 or 2 h) of
ARF6K/D or ARF6 MEFs, by gentamicin protection assay. (C and D, left
graph) Early infection (40 min) of ARF6K/D or ARF6MEFs, with differential
staining of extracellular versus intracellular bacteria. Extracellular bacteria
stained with antibody to LPS (green) and all bacteria identified by DAPI
(DNA, blue). Phalloidin staining of polymerized actin (red). Images are rep-
resentative. Arrows, intracellular bacteria. Arrowheads, extracellular bacteria.
Bar, 10 m. (D, right graph) Rescue of S. flexneri entry by transient transfec-
tion of ARF6K/D MEFs with ARF6-HA. Efficiency of entry into ARF6-HA-
transfected cells was for the subset of cells that expressed ARF6-HA. Mean
standard error of the mean of at least 3 independent experiments.
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ARF6 was precipitated from lysates of infected cells using beads
conjugated to the ARF binding domain of Golgi complex-
associated, gamma adaptin ear-containing ARF binding protein 3
(GGA3), which specifically binds GTP-bound ARF6 (29). WT
S. flexneri induced activation of ARF6 as early as 20 min after
contact with HeLa cells, whereas a strain that is noninvasive by
virtue of lacking the virulence plasmid did not activate ARF6 at
either time assessed (Fig. 2A), indicating that S. flexneri activates
ARF6 soon after cell contact and in a manner that depends on
virulence plasmid-encoded factors.
Exchange of boundGDP forGTP activatesARF6 and recruits it
from a cytosolic pool to the plasma membrane (30–32), suggest-
ing that ARF6 activation during S. flexneri entry might be associ-
ated with its recruitment to entry sites. WT S. flexneri recruited
HA-tagged ARF6 to bacteria at the plasma membrane early in
infection (40min), but the noninvasive strain did not (85% versus
1% of cells displayed ARF6 recruitment to bacteria, P  0.03)
(Fig. 2B and C). In this experiment, to ensure that bacterial con-
tact with the plasma membrane occurred independently of type
III secretion, we used strains that adhered tightly as a result of
heterologous production of the uropathogenic Escherichia coli
afimbrial adhesin (AFA-I); as a result, every cell displayed adher-
ent bacteria. S. flexneri similarly recruited ARF6-HA in MEFs
(18% versus 1% of cells with bacteria associated showed ARF6
recruitment to bacteria, P 0.001) (see Fig. S2 in the supplemen-
tal material); here, only a subset of cells displayed adherent bacte-
ria, as AFA-I was not used because its receptor is absent inmurine
cells. These results show that ARF6 activation by S. flexneri is as-
sociated with its recruitment to bacterial entry sites and is depen-
dent not simply on contact with the plasmamembrane but rather
on virulence plasmid-encoded factors.
The phosphoinositide phosphatase activity of Shigella T3SS
effector IpgD is required for efficient ARF6 activation at entry
sites. We tested whether any of several effector proteins se-
creted into cells by the S. flexneri virulence plasmid-encoded
type III secretion system (T3SS) were required for activation of
ARF6. We postulated that the involved effector was likely to
either possess GTPase exchange factor (GEF) activity or recruit
an ARF GEF to entry sites. We therefore focused on the effec-
tors IpgB1, IpgB2, IpgD, and IpaJ. IpgB1 and IpgB2 possess
GEF activity; IpgB1 principally activates the host GTPases Rac1
and Cdc42, and IpgB2 principally activates RhoA, yet the two
effectors are homologous with some overlap in function (8, 33,
34). IpgD is an inositol 4-phosphatase with no known homol-
ogy to effectors with GEF activity but, like IpgB1, is translo-
cated early upon bacterial contact with host cells and partici-
pates in actin remodeling at entry sites (7, 23, 24). Moreover,
the substrate of IpgD, PI(4,5)P2, is concentrated at the plasma
membrane (35). IpaJ demyristoylates ARF1 (36), an ARF
GTPase that is 66% identical to ARF6 (11).
To test whether any of these effectors is required for S. flexneri-
induced ARF6 activation, we examined the ability of strains lack-
ing each individually to activate ARF6 during entry. Whereas the
other mutant strains examined activated ARF6 at levels compara-
ble to the WT strain, the ipgD mutant was defective in ARF6
activation (Fig. 3A). We then tested whether IpgD was required
for ARF6 recruitment to bacterial entry sites by specifically
assessing the efficiency of ARF6 recruitment to sites where bac-
teria were adherent to cells and/or within a membrane ruffle,
reasoning that these constituted the bulk of the bacterial pop-
ulation potentially undergoing cellular entry. Compared to
WT, the ipgD mutant was defective in ARF6 recruitment
(57% versus 38% of cells with bacteria associated showed ARF6
recruitment, P 0.04) (Fig. 3B, left graph). The ARF6 recruit-
ment defect was rescued by ipgD expressed in trans, but not by
expression of ipgD C438S, a catalytically dead mutant with no
phosphatase activity (24) (54% and 7% of cells with bacteria
associated showed ARF6 recruitment, respectively, P  0.003)
(Fig. 3B, right graph, and C). These results demonstrate that
IpgD phosphatase activity is critical for ARF6 activation and
for ARF6 recruitment to bacterial entry sites.
TheipgDmutant was defective in entry (17% of cells infected
by ipgD mutant versus 31% of cells infected by WT, P 0.002)
(Fig. 3D, left graph), and the entry defect was rescued byWT IpgD
but not by IpgD C438S (68% versus 21% of cells infected, respec-
tively; P 0.0006) (Fig. 3D, right graph). Thus, IpgD phosphatase
activity is required both for activation of ARF6 and for efficient
entry. TheipgDmutant was defective in the formation of plasma
membrane ruffles at entry sites (25% versus 12%of cells displayed
bacteria in a ruffle; P 0.001) (Fig. 3E, left graph). IpgD but not
IpgD C438S rescued the ruffling defect (46% and 4% of cells dis-
played bacteria in a ruffle, respectively; P 0.0016) (Fig. 3E, right
graph). Both the ipgD mutant complemented with WT IpgD
FIG 2 Virulent S. flexneri activates ARF6 early during infection. (A) ARF6
activation determined by pulldownofGTP-boundARF6 fromHeLa cells 20 or
40 min after initial contact of WT or noninvasive S. flexneri (top panel) with
cells, versus total ARF6 in each lysate (bottompanel). GTPS or GDP added to
lysates of uninfected cells and uninfected cells alone (uninfect) are positive and
negative controls. Ratio of ARF6-GTP to total ARF6 for blots shown, by den-
sitometry. Blots are representative. (B and C) ARF6-HA recruitment to AFA-
I-expressing WT or noninvasive S. flexneri in HeLa cells infected (40 min),
fixed, and stained with antibody to HA (green), DAPI (blue), and phalloidin
(red). ND, not detectable. Mean standard error of the mean for 3 indepen-
dent experiments. Images are representative. Arrows, ARF6 recruitment to
entering bacteria. Arrowheads, bacteria without ARF6 recruitment. Bar,
10 m.
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and that complemented with IpgD C438S produced IpgD at
higher levels than the WT strain (see Fig. S3 in the supplemental
material), likely due to plasmid copy number. In the presence of
overexpression ofWT IpgD, entry and ruffle formationweremore
efficient, whereas overexpression of IpgD C438S was associated
with an apparent dominant negative effect on entry and ruffle
formation, further confirming a role for IpgD and IpgD phospha-
tase activity in S. flexneri entry.
Efficient ARF6 recruitment to entering S. flexneri requires
cytohesin GEFs. GEFs activate small GTPases such as ARF6 by
stimulating GDP dissociation, which allows GTP binding. In the
absence of homology that might suggest intrinsic GEF activity, a
mechanism by which IpgD might promote ARF6 activation is by
recruiting and/or activating an ARF6 GEF at S. flexneri entry sites.
Known GEFs of ARF6 include BRAG1, GEP100/BRAG2, EFA6,
and the cytohesin GEFs, cytohesin-1, ARNO (cytohesin-2), and
GRP1 (cytohesin-3) (37–41). We tested whether cytohesin GEFs
are required for S. flexneri entry and for ARF6 recruitment to
entering bacteria by treating cells with SecinH3, a small-molecule
cytohesin family-specific inhibitor (42) that inhibits all cytohesin
FIG 3 The phosphoinositide phosphatase activity of Shigella T3SS effector IpgD is required for efficient ARF6 activation at entry sites. (A) ARF6 activation
determined by pulldown of GTP-bound ARF6 from HeLa cells infected with indicated S. flexneri strains for 40 min after initial bacterial contact with cells (top
panel) versus total ARF6 in each lysate (bottom panel). Ratio of ARF6-GTP to total ARF6 for blots shown, by densitometry. Uninfect, uninfected; Non-invas,
noninvasive strain; ipgB1 B2, ipgB1 ipgB2 mutant. Blots are representative. (B to E) Infection of ARF6-HA-transfected HeLa cells (40 min) with WT,
ipgD,ipgD pIpgD, oripgD pIpgDC438S S. flexneri, fixed and labeled with antibody toHA (green), DAPI (blue), and phalloidin (red). (B) Percentage of cells
with bacteria associated that show ARF6 recruitment to bacteria. (C) Representative images. Arrows, bacteria with ARF6 recruitment. Arrowheads, bacteria
without ARF6 recruitment. Bar, 10 M. (D and E) Percentage of cells infected or with ruffles. Mean  standard error of the mean of at least 3 independent
experiments.
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family GEFs. Cytohesin-1 is highly expressed in natural killer T
lymphocytes (43), whereas ARNO andGRP1 have roles in epithe-
lial cells (17, 44). SecinH3 inhibited S. flexneri entry (30% versus
11% of cells were infected; P  0.04) (Fig. 4A) and ruffle forma-
tion (29% versus 10% of cells displayed bacteria in a ruffle; P
0.02) (Fig. 4B), indicating that one or more cytohesin GEFs
contribute to entry. SecinH3 inhibited S. flexneri entry not only
in the presence of ARF6 (29% versus 14% of ARF6MEFs were
infected, P  0.03) but also in its absence (16% versus 8% of
ARF6K/D MEFs were infected, P  0.02) (data not shown);
since ARNO can activate ARF1 downstream of ARF6 (18, 19),
we speculate that this SecinH3-induced decrease in infection of
ARF6K/D MEFs may be due to inhibition of ARNO-dependent
activation of ARF1.
To determine whether cytohesin GEFs were functioning up-
stream of ARF6 in S. flexneri entry, we tested whether ARF6 re-
cruitment depended on cytohesin activity. In the presence of
SecinH3, ARF6 recruitment to potential entry sites was decreased
(44% versus 15% of cells with bacteria associated showed ARF6
recruitment to bacteria; P 0.001) (Fig. 4C and D), demonstrat-
ing that SecinH3 blocked efficient ARF6 activation by S. flexneri.
Thus, cytohesinGEF activity is critical to efficient ARF6 activation
by entering S. flexneri and to efficient bacterial entry, consistent
with the inhibitory effect of SecinH3 on entry being due at least in
part to inhibition of ARF6 activation.
Interaction of IpgB1 with ELMO, a component of the Rac1
GEF DOCK180/ELMO complex, promotes bacterial uptake (7).
ARNO is required for activation of DOCK180/ELMO (17).
Whether ARNO activation of DOCK180/ELMO depends on
ARF6 is unclear. These observations, in conjunction with the ob-
served effects of SecinH3 on S. flexneri activation of ARF6 and
entry, led us to postulate that ARNO might participate in activa-
tion of ARF6.Myc-tagged ARNOwas recruited to S. flexneri entry
sites. Experimental optimization suggested that membrane ruf-
fling and ARF6 recruitment both peak within 30 to 40 min after
initial bacterial contact with HeLa cells, whereas ARNO recruit-
ment peaks approximately 10 min earlier (data not shown).
ARNO recruitment in HeLa cells depended on the presence of the
virulence plasmid, even for bacteria that expressed the AFA-I ad-
hesin (55% of cells for WT versus 1% of cells for noninvasive
strain displayed ARNO recruitment to bacteria; P  0.001)
(Fig. 5A and B).
Since ARNO recruitment apparently preceded ARF6 recruit-
ment, we tested whether ARNO recruitment might be indepen-
dent of ARF6 by examining its recruitment in ARF6 and
ARF6K/D MEFs. ARNO exists as two splice variants—ARNO 2G
and ARNO 3G—that differ by the addition of a single glycine
residue in the phosphoinositide-binding pocket of the ARNO
pleckstrin homology (PH) domain (45). Because the two variants
display distinct binding preferences for phosphoinositide species
at themembrane (45, 46), we separately examined the recruitment
of each. Each ARNOvariant was independent of ARF6 for recruit-
ment to entering bacteria (42% each of cells with bacteria associ-
ated showed ARNO 2G recruitment to bacteria in ARF6 and
ARF6K/D MEFs, respectively; P 1.0; for ARNO 3G, 42% versus
35%, respectively;P 0.3) (Fig. 5C andD), indicating that ARNO
is recruited upstream of ARF6, which positions it to potentially
contribute to activation of ARF6 at sites of S. flexneri entry. These
findings are notably different fromwhat has been observed during
Salmonella infection, where ARNO recruitment to entry sites is
FIG 4 Efficient ARF6 recruitment to entering S. flexneri requires cytohesin GEFs. Recruitment of ARF6-HA to HeLa cells infected with S. flexneri for 40 min in
the presence of SecinH3 or dimethyl sulfoxide (DMSO). (A) Percentage of cells infected. (B) Percentage of cells with ruffles. (C) Percentage of cells with bacteria
associated showing ARF6 recruitment to bacteria. Mean standard error of the mean of at least 3 independent experiments. (D) Representative images with
labeling with antibody to HA (green), DAPI (blue), and phalloidin (red). Arrows, bacteria with ARF6 recruitment. Arrowheads, bacteria without ARF6
recruitment. Bar, 10 m.
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defective in the absence of ARF6 (19); the reasons for these
organism-based differences are at present unclear.
IpgD and IpgD phosphatase activity are required for ARNO
recruitment to entry sites and S. flexneri entry. IpgD-induced
PI(5)P accumulation activates PI 3-kinase (PI3K), leading to gen-
eration of phosphatidylinositol 3,4,5-trisphosphate [PI(3,4,5)P3]
(47). The PH domains of ARF GEFs bind phosphoinositides with
various affinities; these interactions recruit GEFs to the plasma
membrane (37, 48–50).We considered that recruitment of ARNO
to S. flexneri entry sites might be enhanced by IpgD-mediated
generation of phosphoinositide species that bindARNOwith high
affinity. IpgDwas required for recruitment of ARNO to entry sites
(cells with bacteria associated showing ARNO recruitment to bac-
teria, 59% for WT versus 20% for ipgD mutant, P  0.001)
(Fig. 6A, left graph). IpgD but not IpgD C438S rescued ARNO
recruitment by the ipgD mutant (44% and 5% of cells with bac-
teria associated showed ARNO recruitment to bacteria, respec-
tively) (Fig. 6A, right graph, andB). In the absence of IpgD,ARNO
recruitment was more dramatically reduced than ARF6 recruit-
ment (Fig. 6A, left graph, versus 3B), likely due to a contribution
of other SecinH3-sensitive ARF6GEFs toARF6 recruitment, since
knockdownof ARNOalone did not lead to significant decreases in
ARF6 recruitment (see Fig. S4 in the supplemental material). As
above (Fig. 3D and E), the phosphatase activity of IpgD was re-
quired for both efficient entry and membrane ruffling at entry
sites (see Fig. S5 in the supplemental material). Moreover,
PI(3,4,5)P3 was generated at S. flexneri entry sites, as assessed by
recruitment of a green fluorescent protein (GFP)-tagged pleck-
strin homology domain from Bruton’s tyrosine kinase (BTK-PH-
GFP), which specifically binds PI(3,4,5)P3 (51), and efficient gen-
eration of PI(3,4,5)P3 was dependent on IpgD (ipgD mutant,
18%, versus WT, 37%, for cells displaying BTK-PH-GFP recruit-
ment to entry sites, P 0.04) (Fig. 6C andD). Thus, the phospha-
tase activity of IpgD is critical for both generation of PI(3,4,5)P3 at
entry sites and ARNO recruitment, and IpgD and SecinH3-
sensitive GEFs are each required for ARF6-mediated S. flexneri
entry.
Recruitment to entry sites of ARNO 2G but not ARNO 3G is
defective upon inhibition of PI3K.These data raised the possibil-
ity that IpgD-dependent changes in phosphoinositide composi-
tion, specifically PI3K-dependent generation of PI(3,4,5)P3, con-
tribute to recruitment of ARNO to bacterial entry sites. We tested
whether inhibition of PI3K by addition of the chemical inhibitor
LY294002 to cells during bacterial entry altered recruitment of
ARNO. Recruitment of ARNO 2G, which preferentially binds
PI(3,4,5)P3, was defective in the presence of LY294002 (29% ver-
sus 50% of cells with bacteria attached displaying ARNO recruit-
ment, P 0.04) (Fig. 6E, left graph, and F), whereas recruitment
of ARNO 3G, which binds PI(4,5)P2 with high affinity (45, 46),
was unaffected (30% versus 36%, P 0.4) (Fig. 6E, right graph).
Treatment of cells with LY294002 was associated with defective
phosphorylation of Akt (see Fig. S6 in the supplemental material),
confirming that the conditions used inhibited PI 3-kinase activity.
Thus, IpgD-dependent generation of PI(3,4,5)P3 during entry of
S. flexneri enhances recruitment of the 2G variant of the ARF6
GEF ARNO.
DISCUSSION
Our findings, combined with published data, support the pres-
ence of a positive feedback loop that promotes ARF6 activation
during S. flexneri entry into cells. We demonstrate that activation
of ARF6 is required for efficient entry of S. flexneri into both epi-
thelial cells andMEFs, that ARF6 activation depends on phospha-
tase activity of the T3SS effector IpgD, and that the cytohesin
ARF6GEFARNO is recruited upstream of ARF6where it contrib-
utes to ARF6 activation (Fig. 7). ARF6 activation is known to drive
Rac1-dependent actin remodeling, which promotes membrane
FIG 5 ARNO is recruited to entering S. flexneri independent of ARF6. (A and
B) Recruitment of Myc-ARNO 3G to AFA-I-expressing WT or noninvasive
S. flexneri in HeLa cells, infected for 30 min. Representative images labeled
with antibody to Myc (green), DAPI (blue), and phalloidin (red). (C and D)
Recruitment of Myc-ARNO 2G or Myc-ARNO 3G to S. flexneri entering
ARF6K/D or ARF6MEFs, infected for 25min. Labeling as in panel B. Arrows,
entering bacteria with ARNO recruitment. Arrowheads, bacteria without
ARNO recruitment. ND, not detectable. NS, not significant.Mean standard
error of the mean of at least 3 independent experiments. Bars, 10 m.
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ruffle formation and bacterial entry (16, 17). Thus, the amplifica-
tion of signals immediately beneath sites of bacterial contact with
the plasmamembrane that result from this positive feedback loop
would be expected to promote rapid local changes that facilitate
bacterial entry.
In a positive feedback loop, amplification allows the output
signal to reach a critical threshold at which the system switches
from one state to another, traditionally basal to active (52). Posi-
tive feedback loops have been reported for Rab (53, 54) and ARF
(55, 56) GTPase signaling. ARNO recruitment to the plasma
membrane is by two distinct mechanisms: binding to phosphoi-
nositides and phosphatidylserine and binding to ARF6 (57, 58). In
an ARF6 feedback loop, GTP-boundARF6 stimulates ARNO, and
ARNO activates ARF1 and is then stimulated by GTP-bound
ARF1 (55). Cohen et al. found that GTP-bound ARF6 binds the
ARNO PH domain, leading to ARNO recruitment to the plasma
membrane and activation of ARF1 (57). Cascades of GEFs and
GTPases can thus constitute positive feedback loops that feed back
onto themselves.
The positive feedback loop that our data support is distinct
from described GEF cascades in that IpgD phosphatase activity
generates signals that contribute to GEF recruitment. These sig-
nals include the generation of membrane-anchored phosphoino-
sitide species that bind ARNO. Since PI(4,5)P2, the substrate for
IpgD phosphatase activity, is generated by ARF6-mediated activa-
tion of PIP5K, by ourmodel, IpgD activity is fueled by its ability to
generate phosphoinositides that enhance ARNO recruitment.
Moreover, because inactive ARF6 does not bind the ARNO PH
FIG 6 IpgD phosphatase activity is required for ARNO recruitment to entry sites, and PI 3-kinase contributes to ARNO 2G but not ARNO 3G recruitment. (A
and B)WT,ipgD,ipgD pIpgD, andipgD pIpgD C438S S. flexneri infection for 30 min of HeLa cells transfected withMyc-ARNO 3G. (A) Percentage of cells
with ARNO recruitment to entering bacteria. (B) Representative images, labeled with antibody to Myc (green), DAPI (blue), and phalloidin (red). (C and D)
Recruitment of PI(3,4,5)P3 to bacterial entry sites uponWT oripgD infection for 40 min of HeLa cells transfected with BTK-PH-GFP, which specifically binds
PI(3,4,5)P3. (C) Percentage of cells with BTK-PH-GFP recruitment to entering bacteria. (D) Representative images, labeled with DAPI (blue), and phalloidin
(red), and with GFP signal. (E and F) Inhibition of recruitment of ARNO 2G, but not ARNO 3G, upon treatment with LY294002 uponWT infection of ARF6K/D
MEFs for 25 min. (E) Percentage of cells with ARNO recruitment to entering bacteria. (F) Representative images, labeled as in panel B. Arrows, bacteria with
ARNO recruitment. Arrowheads, bacteria without ARNO recruitment. Bars, 10 m. NS, not significant. Mean  standard error of the mean of at least 3
independent experiments. DMSO, dimethyl sulfoxide; LY, LY294002.
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domain (57), IpgD-generated phosphoinositides may function as
the seed for ARNO recruitment and subsequent ARF6 recruit-
ment and activation. This model, supported by the data presented
here, predicts that IpgD activity expands the existing GEF-ARF
cascade in a manner that further amplifies ARF6 activation.
Our findings establish a substantial expansion of the model of
ARF GTPase participation in entry, previously described for Sal-
monella enterica serovar Typhimurium by Humphreys et al. (18,
19). Data from the prior studies support a model in which ARF6
recruits ARNO,ARNO in turn recruits ARF1, andARF1promotes
actin polymerization via the WAVE regulatory complex (18, 19).
In our work here, in addition to showing that entry by S. flexneri
parallels that of S. Typhimurium with respect to participation
of ARFGTPases, we characterize for the first time amechanism of
activation ofARF6 in this process anddemonstrate the presence of
the previously undescribed positive feedback loop that likely am-
plifies ARF6 activation. Moreover, our results identify an impor-
tant difference from the entry of S. Typhimurium, wherein ARNO
recruitment is dependent on ARF6 (19), in that during entry of
S. flexneri, ARNO recruitment is independent of and occurs up-
stream of ARF6. Although the reasons are currently unclear, these
findings may highlight the existence of important functional di-
vergence between Shigella and Salmonella.
An important insight that emerges fromour data together with
published data (18, 19) is that during bacterial entry, ARNO par-
ticipates in the activation of both ARF6 and ARF1, which lies
downstream of ARF6. Thus, ARF GEFs such as ARNO (but per-
haps not restricted to ARNO) may participate promiscuously at
multiple steps during bacterial infection. ARNO recruitment was
absolutely dependent on IpgD. The effector IpgB1 recruits the
Rac1 GEF DOCK180/ELMO to entry sites (7). DOCK180/ELMO
is activated by ARF6 via ARF1 and dependent on ARNO GEF
activity (17, 19).
PI(4,5)P2 is relatively abundant in both resting and stimu-
lated cells, whereas PI(3,4,5)P3 is detectable only following
stimulation (59). IpgD phosphatase activity leads to the recruit-
ment of PI(3,4,5)P3 (Fig. 6C and D). PI(4,5)P2 and PI(3,4,5)P3
bind PH domains of ARF GEFs. The high-affinity interaction of
membrane-anchored PI(3,4,5)P3 with the ARNO 2G variant is
sufficient to recruit it to the plasma membrane, whereas the low-
affinity interaction of PI(3,4,5)P3with theARNO3Gvariant is not
sufficient (45, 60, 61). In brain tissue, the 3G variant of ARNO is
most abundant (46); the relative abundance of the two variants in
other tissues is unknown.
Recruitment of ARNO to S. flexneri entry sites is dependent on
IpgDphosphatase activity (Fig. 6A toC) and independent ofARF6
(Fig. 5). The reduction in recruitment of the 2G variant of ARNO
upon chemical inhibition of PI 3-kinase (Fig. 6E and F) is consis-
tent with a model in which transient PI(3,4,5)P3 accumulation,
induced by IpgD-dependent activation of PI 3-kinase, leads to
efficient recruitment of ARNO 2G via its high-affinity interaction
with PI(3,4,5)P3. However, recruitment of ARNO 3G is indepen-
dent of PI(3,4,5)P3 accumulation (Fig. 6D) and thus must be me-
diated by other factors that accumulate at entry sites in response to
IpgD phosphatase activity.
Our data demonstrate for the first time that IpgD is required
for efficient S. flexneri entry. Of note, although statistically signif-
icant, the defect in entry of the ipgD mutant is relatively minor
(Fig. 3D). That the relatively small defect is meaningful is sup-
ported by the enhanced entry observed upon overexpression of
IpgD (Fig. 3D). The presence of only a minor defect is also con-
sistent with several lines of evidence that point to Shigella entry
resulting from multiple partially redundant mechanisms medi-
ated by various T3SS effectors (5, 7, 8). The relatively small de-
crease observed, along with differences in strain backgrounds,
likely explains why the role of IpgD in entry has been unappreci-
ated in other experimental systems (62, 63).
IpgD phosphatase activity and the phosphoinositides that it
generates have previously been implicated in S. flexneri activa-
tion of Akt (47), regulation of vesicular trafficking (64), re-
cruitment of Rab-11-containing vesicles to bacterial uptake
vacuoles (63), inhibition of chemokine-inducedmigration of T
FIG 7 Model of IpgD-dependent positive feedback loop that amplifies ARF6 activation during entry of S. flexneri. Extracellular S. flexneri recruits ARNO to the
plasma membrane in part via IpgD-induced local accumulation of PI(3,4,5)P3. ARNO-dependent activation of ARF6 induces PIP5K-mediated changes in
phosphoinositide composition at the membrane that promote additional ARNO recruitment, mediating further activation of ARF6. Solid arrows, relationships
supported by data presented here or previously published. Dashed arrows, postulated relationships.
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cells (65), inhibition of ATP release through connexin hemi-
channels (66), and activation of the GEF Tiam1 in Rac1-
mediated actin rearrangements (67). Our data now add to the
list a role in entry via activation of ARF6. Themultiple effects of
IpgD during S. flexneri infection highlight the central role that
phosphoinositides play in intracellular signaling and the extent
to which S. flexneri has evolved mechanisms to manipulate
these signaling pathways.
MATERIALS AND METHODS
Bacterial strains, plasmids, andgrowth conditions. Strains andplasmids
are listed in Table 1. All S. flexneri strains are isogenic to serotype 2a
wild-type strain 2457T (68). S. flexneri bacteria were grown at 37°C in
tryptic soy broth from individual Congo red-positive colonies. Antibiotics
were ampicillin (Amp), 100 g/ml; chloramphenicol (Cm), 25 g/ml;
and kanamycin (Km), 50 g/ml. To generate pIpgD and pIpgD C438S,
the coding sequences of ipgD, its promoter, and its chaperone ipgE were
cloned into pACYC184 with site-directed mutagenesis of pIpgD
(QuikChange mutagenesis kit; Stratagene).
Cell culture. HeLa cells were cultured in high-glucose Dulbecco’s
modified Eagle’s medium (DMEM; Gibco), and ARF6K/D and ARF6
mouse embryonic fibroblasts (MEFs) (gift of Wim Annaert [26]) were
cultured in DMEM–nutrient mixture F-12, each with 10% fetal bovine
serum. Monolayers were transfected 24 h prior to infection with 1.5 g
DNA and Fugene 6 transfection reagent (Promega). Knockdown of
ARNO was performed using the ARNO-specific small interfering RNAs
(siRNAs) Hs_PSCD2_2 SI00061292, Hs_PSCD2_3 SI00061299, Hs_P-
SCD2_6 SI03050894, and Hs_PSCD2_7 SI03072629 or AllStars negative-
control siRNA SI03650318 (Qiagen) and HiPerFect transfection reagent
(Qiagen).
Infection of cells. Bacteria (optical density at 600 nm [OD600], 0.3 to
0.4) were added to cell monolayers at a multiplicity of infection (MOI) of
200 to 300:1 (bacteria to cell) or, for strains containing pIL22, at an MOI
of 10:1. Cells were centrifuged at 700 g for 10min and then incubated at
37°C for a specified additional period of time. SecinH3 (2.5 M; Calbio-
chem) or LY294002 (50M; Cell Signaling; catalog no. 9901S) was added
immediately prior to addition of bacteria. Infected monolayers were
washed, fixed in 3.7%paraformaldehyde for 15 to 20min, and permeabil-
ized with 1% Triton X-100. Labeling was performed using antibodies to
S. flexneri 2a lipopolysaccharide (LPS; Gibco) or HA (Covance MMS-
101P) or with Myc (Clontech 631206), phalloidin (Invitrogen), or DAPI
(100 M; Invitrogen).
Gentamicin protection assay. Cells seeded at 3  105 per well of a
6-well dish were infected at anMOI of 0.02:1 (69); incubated at 37°C for 5
or 50 min; washed three times; incubated for an additional 45 or 60 min,
respectively, in DMEM containing 50 g/ml gentamicin to kill extracel-
lular bacteria; and lysed with 0.5 to 1% Triton X-100. Bacteria in cell
lysates and in the initial inoculum were determined by plating.
Protein production and secretion. Synthesis and secretion of IpgD
were assayed essentially as described previously (70). Proteins were re-
solved by SDS-PAGE and probed with IpgD (gift of A. Phalipon [24]) or
DnaK (StressGen) antibody.
Pulldown assay. GTP-bound ARF6 in infected monolayers was mea-
sured per the manufacturer’s instructions (Cytoskeleton, Inc.). Briefly,
cells were infected at an MOI of 300:1 (as described above), followed by
incubation for an additional 10 or 30min, lysis on ice, and harvesting and
snap-freezing of the lysate. Two hundred fifty micrograms of each lysate
was incubated with beads covalently conjugated to the ARF6 binding
domain of GGA3 for 1 h at 4°C. Beads were washed and recovered. Bound
ARF6was resolved by SDS-PAGE and analyzed using ARF6 antibody (gift
of J. Donaldson). Other antibodies used were phosphor-Akt S473 and
pan-Akt (Cell Signaling) and ARNO (Abcam ab56510).
Microscopy and data analysis. Microscopy was performed on a
Nikon Eclipse TE300 or TE2000 microscope with Chroma Technology
filters. For all sets of experiments, three ormore independent experiments
were performed. Samples were blinded. At least 10 infected cells were
analyzed for each condition. A bacteriumwas counted as entering the cell
if it was found associated with a membrane ruffle, determined by actin
staining and phase microscopy, and as potentially undergoing bacterial
entry if it was adherent and/or within a membrane ruffle. A cell was
counted as infected if at least one bacterium was entering or present
within the cell. The significance of differences between two-way com-
parisons was determined by paired t test. The significance of differ-
ences among multiple sets of data was determined by one-way analysis
of variance (ANOVA) followed by a post hoc Tukey comparison.
SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at http://mbio.asm.org/
lookup/suppl/doi:10.1128/mBio.02584-14/-/DCSupplemental.
TABLE 1 Bacterial strains and plasmids used in this study
Strain or plasmid Genotype or description Reference or source
Bacterial strains
Wild type Serotype 2a S. flexneri strain 2457t 68
Noninvasive BS103 (2457T cured of its virulence plasmid) 71
Wild type with adhesin 2457T pIL22, Ampr Lab stock
Noninvasive with adhesin BS103 pIL22, Ampr Lab stock
ipgD mutant 2457T ipgD::FRT-Kmr-FRTa Gift of C. Lesser
ipgD pIpgD mutant 2457T ipgD::FRT-Kmr-FRT pACYC184 ipgD-ipgE This study
ipgD pIpgD C438S mutant 2457T ipgD::FRT-Kmr-FRT pACYC184 ipgD C438S-ipgE This study
ipgB1 mutant 2457T ipgB1::FRT Lab stock
ipgB1 ipgB2 mutant 2457T ipgB1::FRT ipgB2::FRT Lab stock
ipaJ mutant 2457T ipaJ::FRT Lab stock
Plasmids
pACYC184 Cmr Lab stock
pIpgD pACYC184 ipgD-ipgE, Cmr This study
pIpgD C438S pACYC184 ipgD C438S-ipgE, Cmr This study
pIL22 pBR322 encoding Escherichia coli afimbrial adhesin AFA-I, Ampr 72
ARF6-HA pcDNA HA-tagged ARF6, Ampr 21
ARF6 N122I-HA pcDNA HA-tagged ARF6 defective for nucleotide binding, Ampr 21
BTK-PH-GFP pEGFP-N1-BTK-PH-GFP, Kmr 51
Myc-ARNO 3G pcDNA3 Myc-tagged ARNO, 3G variant, Ampr 29
Myc-ARNO 2G pcDNA3 Myc-tagged ARNO, 2G variant, Ampr Gift of L. Santy
a FRT, FLP recombination target.
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Figure S1, TIF file, 0.6 MB.
Figure S2, TIF file, 2.7 MB.
Figure S3, TIF file, 0.2 MB.
Figure S4, TIF file, 1.4 MB.
Figure S5, TIF file, 0.3 MB.
Figure S6, TIF file, 0.2 MB.
ACKNOWLEDGMENTS
We acknowledge C. R. Yi and S. Y. Lee for bacterial strain construction
and B. B. Herrera for technical support. We thank W. Annaert, J. G.
Donaldson, L. C. Santy, R. R. Isberg, A. Phalipon, H. Ploegh, and C. F.
Lesser for providing reagents; V. W. Hsu for helpful advice; and J. R.
Mayers for critical reading of the manuscript.
This work was supported by Public Health Service grant R01AI081724
(to M.B.G.), trainee support on T32GM007753 (to A.C.G.-M.), and
T32AI007061 (to K.A.M. and B.C.R.) from the National Institutes of
Health.
REFERENCES
1. Hale TL. 1991. Genetic basis of virulence in Shigella species. Microbiol
Rev 55:206–224.
2. Sansonetti PJ, Kopecko DJ, Formal SB. 1982. Involvement of a plasmid
in the invasive ability of Shigella flexneri. Infect Immun 35:852–860.
3. Sasakawa C, Kamata K, Sakai T, Makino S, Yamada M, Okada N,
Yoshikawa M. 1988. Virulence-associated genetic regions comprising 31
kilobases of the 230-kilobase plasmid in Shigella flexneri 2a. J Bacteriol
170:2480–2484.
4. Schroeder GN, Hilbi H. 2008. Molecular pathogenesis of Shigella spp.:
controlling host cell signaling, invasion, and death by type III secre-
tion. Clin Microbiol Rev 21:134 –156. http://dx.doi.org/10.1128/
CMR.00032-07.
5. Tran Van Nhieu G, Ben-Ze’ev A, Sansonetti PJ. 1997. Modulation of
bacterial entry into epithelial cells by association between vinculin and the
Shigella IpaA invasin. EMBO J 16:2717–2729. http://dx.doi.org/10.1093/
emboj/16.10.2717.
6. Mounier J, Laurent V, Hall A, Fort P, Carlier MF, Sansonetti PJ, Egile
C. 1999. Rho family GTPases control entry of Shigella flexneri into epithe-
lial cells but not intracellular motility. J Cell Sci 112:2069–2080.
7. Handa Y, Suzuki M, Ohya K, Iwai H, Ishijima N, Koleske AJ, Fukui Y,
Sasakawa C. 2007. Shigella IpgB1 promotes bacterial entry through the
ELMO-Dock180 machinery. Nat Cell Biol 9:121–128. http://dx.doi.org/
10.1038/ncb1526.
8. Hachani A, Biskri L, Rossi G, Marty A, Ménard R, Sansonetti P, Parsot
C, Van Nhieu GT, Bernardini ML, Allaoui A. 2008. IpgB1 and IpgB2,
two homologous effectors secreted via the Mxi-Spa type III secretion ap-
paratus, cooperate to mediate polarized cell invasion and inflammatory
potential of Shigella flexneri. Microbes Infect 10:260 –268. http://
dx.doi.org/10.1016/j.micinf.2007.11.011.
9. Takai Y, Sasaki T, Matozaki T. 2001. Small GTP-binding proteins.
Phys io l Rev 81:153–208. ht tp : / /dx .doi .org/10 .1016/S0074
-7696(08)61861-6.
10. Baxt LA, Garza-Mayers AC, Goldberg MB. 2013. Bacterial subversion of
host innate immune pathways. Science 340:697–701. http://dx.doi.org/
10.1126/science.1235771.
11. D’Souza-Schorey C, Chavrier P. 2006. ARF proteins: roles in membrane
traffic and beyond. Nat Rev Mol Cell Biol 7:347–358. http://dx.doi.org/
10.1038/nrm1910.
12. Donaldson JG, Jackson CL. 2011. ARF family G proteins and their
regulators: roles in membrane transport, development and disease. Nat
Rev Mol Cell Biol 12:362–375. http://dx.doi.org/10.1038/nrm3117.
13. Honda A, Nogami M, Yokozeki T, Yamazaki M, Nakamura H,
Watanabe H, Kawamoto K, Nakayama K, Morris AJ, Frohman MA,
Kanaho Y. 1999. Phosphatidylinositol 4-phosphate 5-kinase alpha is a
downstream effector of the small G protein ARF6 in membrane ruffle
formation. Cell 99:521–532. http://dx.doi.org/10.1016/S0092
-8674(00)81540-8.
14. D’Souza-Schorey C, Li G, Colombo MI, Stahl PD. 1995. A regulatory
role for ARF6 in receptor-mediated endocytosis. Science 267:1175–1178.
http://dx.doi.org/10.1126/science.7855600.
15. Peters PJ, Hsu VW, Ooi CE, Finazzi D, Teal SB, Oorschot V, Donald-
son JG, Klausner RD. 1995. Overexpression of wild-type and mutant
ARF1 and ARF6: distinct perturbations of nonoverlapping membrane
compartments. J Cell Biol 128:1003–1017. http://dx.doi.org/10.1083/
jcb.128.6.1003.
16. Radhakrishna H, Al-Awar O, Khachikian Z, Donaldson JG. 1999. ARF6
requirement for Rac ruffling suggests a role for membrane trafficking in
cortical actin rearrangements. J Cell Sci 112:855–866.
17. Santy LC, Ravichandran KS, Casanova JE. 2005. The DOCK180/Elmo
complex couples ARNO-mediated Arf6 activation to the downstream ac-
tivation of Rac1. Curr Biol 15:1749–1754. http://dx.doi.org/10.1016/
j.cub.2005.08.052.
18. Humphreys D, Davidson A, Hume PJ, Koronakis V. 2012. Salmonella
virulence effector SopE and host GEF ARNO cooperate to recruit and
activate WAVE to trigger bacterial invasion. Cell Host Microbe 11:
129–139. http://dx.doi.org/10.1016/j.chom.2012.01.006.
19. Humphreys D, Davidson AC, Hume PJ, Makin LE, Koronakis V. 2013.
Arf6 coordinates actin assembly through the WAVE complex, a mecha-
nism usurped by Salmonella to invade host cells. Proc Natl Acad Sci U S A
110:16880–16885. http://dx.doi.org/10.1073/pnas.1311680110.
20. Balañá ME, Niedergang F, Subtil A, Alcover A, Chavrier P, Dautry-
Varsat A. 2005. ARF6 GTPase controls bacterial invasion by actin
remodelling. J Cell Sci 118:2201–2210. http://dx.doi.org/10.1242/
jcs.02351.
21. Wong KW, Isberg RR. 2003. Arf6 and phosphoinositol-4-phosphate-5-
kinase activities permit bypass of the Rac1 requirement for beta1 integrin-
mediated bacterial uptake. J Exp Med 198:603–614. http://dx.doi.org/
10.1084/jem.20021363.
22. Selyunin AS, Sutton SE, Weigele BA, Reddick LE, Orchard RC, Bresson
SM, Tomchick DR, Alto NM. 2011. The assembly of a GTPase-kinase
signalling complex by a bacterial catalytic scaffold. Nature 469:107–111.
http://dx.doi.org/10.1038/nature09593.
23. Le Gall T, Mavris M, Martino MC, Bernardini ML, Denamur E,
Parsot C. 2005. Analysis of virulence plasmid gene expression defines
three classes of effectors in the type III secretion system of Shigella
flexneri. Microbiology 151:951–962. http://dx.doi.org/10.1099/
mic.0.27639-0.
24. Niebuhr K, Giuriato S, Pedron T, Philpott DJ, Gaits F, Sable J, Sheetz
MP, Parsot C, Sansonetti PJ, Payrastre B. 2002. Conversion of
PtdIns(4,5)P(2) into PtdIns(5)P by the S. flexneri effector IpgD reorga-
nizes host cell morphology. EMBO J 21:5069–5078. http://dx.doi.org/
10.1093/emboj/cdf522.
25. Niebuhr K, Jouihri N, Allaoui A, Gounon P, Sansonetti PJ, Parsot C.
2000. IpgD, a protein secreted by the type III secretion machinery of Shi-
gella flexneri, is chaperoned by IpgE and implicated in entry focus forma-
tion. Mol Microbiol 38:8 –19. http://dx.doi.org/10.1046/j.1365
-2958.2000.02041.x.
26. Sannerud R, Declerck I, Peric A, Raemaekers T, Menendez G, Zhou L,
Veerle B, Coen K, Munck S, De Strooper B, Schiavo G, Annaert W.
2011. ADP ribosylation factor 6 (ARF6) controls amyloid precursor pro-
tein (APP) processing by mediating the endosomal sorting of BACE1.
Proc Natl Acad Sci U S A 108:E559–E568. http://dx.doi.org/10.1073/
pnas.1100745108.
27. Sansonetti PJ, Ryter A, Clerc P, Maurelli AT, Mounier J. 1986. Multi-
plication of Shigella flexneri within HeLa cells: lysis of the phagocytic vac-
uole and plasmid-mediated contact hemolysis. Infect Immun 51:
461–469.
28. Ray K, Bobard A, Danckaert A, Paz-Haftel I, Clair C, Ehsani S, Tang C,
Sansonetti P, Tran GV, Enninga J. 2010. Tracking the dynamic interplay
between bacterial and host factors during pathogen-induced vacuole rup-
ture in real time. Cell Microbiol 12:545–556. http://dx.doi.org/10.1111/
j.1462-5822.2010.01428.x.
29. Santy LC, Casanova JE. 2001. Activation of ARF6 by ARNO stimulates
epithelial cell migration through downstream activation of both Rac1 and
phospholipase D. J Cell Biol 154:599–610. http://dx.doi.org/10.1083/
jcb.200104019.
30. Antonny B, Beraud-Dufour S, Chardin P, Chabre M. 1997. N-terminal
hydrophobic residues of the G-protein ADP-ribosylation factor-1 insert
intomembrane phospholipids uponGDP toGTP exchange. Biochemistry
36:4675–4684. http://dx.doi.org/10.1021/bi962252b.
31. Gaschet J, Hsu VW. 1999. Distribution of ARF6 between membrane and
cytosol is regulated by its GTPase cycle. J Biol Chem 274:20040–20045.
http://dx.doi.org/10.1074/jbc.274.28.20040.
32. Yang CZ, Heimberg H, D’Souza-Schorey C, Mueckler MM, Stahl PD.
1998. Subcellular distribution and differential expression of endogenous
Garza-Mayers et al.
10 ® mbio.asm.org March/April 2015 Volume 6 Issue 2 e02584-14
ADP-ribosylation factor 6 in mammalian cells. J Biol Chem 273:
4006–4011. http://dx.doi.org/10.1074/jbc.273.7.4006.
33. Huang Z, Sutton SE, Wallenfang AJ, Orchard RC, Wu X, Feng Y, Chai
J, Alto NM. 2009. Structural insights into host GTPase isoform selection
by a family of bacterial GEF mimics. Nat Struct Mol Biol 16:853–860.
http://dx.doi.org/10.1038/nsmb.1647.
34. Alto NM, Shao F, Lazar CS, Brost RL, Chua G, Mattoo S, McMahon SA,
Ghosh P, Hughes TR, Boone C, Dixon JE. 2006. Identification of a
bacterial type III effector family with G protein mimicry functions. Cell
124:133–145. http://dx.doi.org/10.1016/j.cell.2005.10.031.
35. Lu R, Goldberg MB. 2010. Bacterial exploitation of host cell signaling. Sci
Transl Med 2:51ps48. http://dx.doi.org/10.1126/scitranslmed.3001612.
36. Burnaevskiy N, Fox TG, Plymire DA, Ertelt JM, Weigele BA, Selyunin
AS, Way SS, Patrie SM, Alto NM. 2013. Proteolytic elimination of
N-myristoyl modifications by the Shigella virulence factor IpaJ. Nature
496:106–109. http://dx.doi.org/10.1038/nature12004.
37. Langille SE, Patki V, Klarlund JK, Buxton JM, Holik JJ, Chawla A,
Corvera S, Czech MP. 1999. ADP-ribosylation factor 6 as a target of
guanine nucleotide exchange factorGRP1. J Biol Chem 274:27099–27104.
http://dx.doi.org/10.1074/jbc.274.38.27099.
38. Frank S, Upender S, Hansen SH, Casanova JE. 1998. ARNO is a guanine
nucleotide exchange factor for ADP-ribosylation factor 6. J Biol Chem
273:23–27. http://dx.doi.org/10.1074/jbc.273.1.23.
39. Myers KR, Wang G, Sheng Y, Conger KK, Casanova JE, Zhu JJ. 2012.
Arf6-GEF BRAG1 regulates JNK-mediated synaptic removal of GluA1-
containing AMPA receptors: a new mechanism for nonsyndromic
X-linked mental disorder. J Neurosci 32:11716–11726. http://dx.doi.org/
10.1523/JNEUROSCI.1942-12.2012.
40. Ikenouchi J, Umeda M. 2010. FRMD4A regulates epithelial polarity by
connecting Arf6 activation with the PAR complex. Proc Natl Acad Sci
U S A 107:748–753. http://dx.doi.org/10.1073/pnas.0908423107.
41. Sabe H, Hashimoto S, Morishige M, Ogawa E, Hashimoto A, Nam JM,
Miura K, Yano H, Onodera Y. 2009. The EGFR-GEP100-Arf6-AMAP1
signaling pathway specific to breast cancer invasion andmetastasis. Traffic
10:982–993. http://dx.doi.org/10.1111/j.1600-0854.2009.00917.x.
42. Hafner M, Schmitz A, Grüne I, Srivatsan SG, Paul B, Kolanus W, Quast
T, Kremmer E, Bauer I, Famulok M. 2006. Inhibition of cytohesins by
SecinH3 leads to hepatic insulin resistance. Nature 444:941–944. http://
dx.doi.org/10.1038/nature05415.
43. Liu L, Pohajdak B. 1992. Cloning and sequencing of a human cDNA from
cytolytic NK/T cells with homology to yeast SEC7. Biochim Biophys Acta
1132:75–78. http://dx.doi.org/10.1016/0167-4781(92)90055-5.
44. Li J, Malaby AW, Famulok M, Sabe H, Lambright DG, Hsu VW.
2012. Grp1 plays a key role in linking insulin signaling to glut4 recy-
c l ing . Dev Cel l 22:1286 –1298. ht tp : / /dx .doi .org/10 .1016/
j.devcel.2012.03.004.
45. Klarlund JK, Tsiaras W, Holik JJ, Chawla A, Czech MP. 2000. Distinct
polyphosphoinositide binding selectivities for pleckstrin homology
domains of GRP1-like proteins based on diglycine versus triglycine mo-
tifs. J Biol Chem 275:32816 –32821. http://dx.doi.org/10.1074/
jbc.M002435200.
46. Ogasawara M, Kim SC, Adamik R, Togawa A, Ferrans VJ, Takeda K,
Kirby M, Moss J, Vaughan M. 2000. Similarities in function and gene
structure of cytohesin-4 and cytohesin-1, guanine nucleotide-exchange
proteins for ADP-ribosylation factors. J Biol Chem 275:3221–3230. http://
dx.doi.org/10.1074/jbc.275.5.3221.
47. Pendaries C, Tronchère H, Arbibe L, Mounier J, Gozani O, Cantley L,
Fry MJ, Gaits-Iacovoni F, Sansonetti PJ, Payrastre B. 2006. PtdIns5P
activates the host cell PI3-kinase/Akt pathway during Shigella flexneri
infection. EMBO J. 25:1024 –1034. http://dx.doi.org/10.1038/
sj.emboj.7601001.
48. Klarlund JK, Guilherme A, Holik JJ, Virbasius JV, Chawla A, Czech
MP. 1997. Signaling by phosphoinositide-3,4,5-trisphosphate through
proteins containing pleckstrin and Sec7 homology domains. Science 275:
1927–1930. http://dx.doi.org/10.1126/science.275.5308.1927.
49. Venkateswarlu K, Oatey PB, Tavaré JM, Cullen PJ. 1998. Insulin-
dependent translocation of ARNO to the plasmamembrane of adipocytes
requires phosphatidylinositol 3-kinase. Curr Biol 8:463–466. http://
dx.doi.org/10.1016/S0960-9822(98)70181-2.
50. Nagel W, Schilcher P, Zeitlmann L, Kolanus W. 1998. The PH domain
and the polybasic c domain of cytohesin-1 cooperate specifically in plasma
membrane association and cellular function. Mol Biol Cell 9:1981–1994.
http://dx.doi.org/10.1091/mbc.9.8.1981.
51. Manna D, Albanese A, Park WS, Cho W. 2007. Mechanistic basis of
differential cellular responses of phosphatidylinositol 3,4-bisphosphate-
and phosphatidylinositol 3,4,5-trisphosphate-binding pleckstrin homol-
ogy domains. J Biol Chem 282:32093–32105. http://dx.doi.org/10.1074/
jbc.M703517200.
52. Brandman O, Meyer T. 2008. Feedback loops shape cellular signals in
space and time. Science 322:390 –395. http://dx.doi.org/10.1126/
science.1160617.
53. Feng S, Knödler A, Ren J, Zhang J, Zhang X, Hong Y, Huang S, Peränen
J, Guo W. 2012. A Rab8 guanine nucleotide exchange factor-effector
interaction network regulates primary ciliogenesis. J Biol Chem 287:
15602–15609. http://dx.doi.org/10.1074/jbc.M111.333245.
54. Ortiz D, Medkova M,Walch-Solimena C, Novick P. 2002. Ypt32 recruits
the Sec4p guanine nucleotide exchange factor, Sec2p, to secretory vesicles;
evidence for a Rab cascade in yeast. J Cell Biol 157:1005–1015. http://
dx.doi.org/10.1083/jcb.200201003.
55. Stalder D, Barelli H, Gautier R, Macia E, Jackson CL, Antonny B.
2011. Kinetic studies of the Arf activator Arno on model membranes in
the presence of Arf effectors suggest control by a positive feedback
loop. J Biol Chem 286:3873–3883. http://dx.doi.org/10.1074/
jbc.M110.145532.
56. Richardson BC, McDonold CM, Fromme JC. 2012. The Sec7 Arf-GEF is
recruited to the trans-Golgi network by positive feedback. Dev Cell 22:
799–810. http://dx.doi.org/10.1016/j.devcel.2012.02.006.
57. Cohen LA, Honda A, Varnai P, Brown FD, Balla T, Donaldson JG.
2007. Active Arf6 recruits ARNO/cytohesin GEFs to the PM by binding
their PH domains. Mol Biol Cell 18:2244 –2253. http://dx.doi.org/
10.1091/mbc.E06-11-0998.
58. Macia E, Paris S, Chabre M. 2000. Binding of the PH and polybasic
C-terminal domains of ARNO to phosphoinositides and to acidic lipids.
Biochemistry 39:5893–5901. http://dx.doi.org/10.1021/bi992795w.
59. Auger KR, Cantley LC. 1991. Novel polyphosphoinositides in cell growth
and activation. Cancer Cells 3:263–270.
60. DiNitto JP, Cronin TC, Lambright DG. 2003. Membrane recognition
and targeting by lipid-binding domains. Sci STKE 2003:re16. http://
dx.doi.org/10.1126/stke.2132003re16.
61. Cronin TC, DiNitto JP, Czech MP, Lambright DG. 2004. Structural
determinants of phosphoinositide selectivity in splice variants of Grp1
family PH domains. EMBO J 23:3711–3720. http://dx.doi.org/10.1038/
sj.emboj.7600388.
62. Allaoui A, Ménard R, Sansonetti PJ, Parsot C. 1993. Characterization of
the Shigella flexneri ipgD and ipgF genes, which are located in the proximal
part of the mxi locus. Infect Immun 61:1707–1714.
63. Mellouk N, Weiner A, Aulner N, Schmitt C, Elbaum M, Shorte SL,
Danckaert A, Enninga J. 2014. Shigella subverts the host recycling com-
partment to rupture its vacuole. Cell Host Microbe 16:517–530. http://
dx.doi.org/10.1016/j.chom.2014.09.005.
64. Ramel D, Lagarrigue F, Pons V, Mounier J, Dupuis-Coronas S, Chi-
canne G, Sansonetti PJ, Gaits-Iacovoni F, Tronchère H, Payrastre B.
2011. Shigella flexneri infection generates the lipid PI5P to alter endocyto-
sis and prevent termination of EGFR signaling. Sci Signal 4:ra61. http://
dx.doi.org/10.1126/scisignal.2001619.
65. Konradt C, Frigimelica E, Nothelfer K, Puhar A, Salgado-Pabon W, di
Bartolo V, Scott-Algara D, Rodrigues CD, Sansonetti PJ, Phalipon A.
2011. The Shigella flexneri type three secretion system effector IpgD inhib-
its T cell migration by manipulating host phosphoinositide metabolism.
Ce l l Host Microbe 9:263–272. ht tp : / /dx .doi .org/10 .1016/
j.chom.2011.03.010.
66. Puhar A, Tronchère H, Payrastre B, Nhieu GT, Sansonetti PJ. 2013.
A Shigella effector dampens inflammation by regulating epithelial re-
lease of danger signal ATP through production of the lipid mediator
PtdIns5P. Immunity 39:1121–1131. http://dx.doi.org/10.1016/
j.immuni.2013.11.013.
67. Viaud J, Lagarrigue F, Ramel D, Allart S, Chicanne G, Ceccato L,
Courilleau D, Xuereb JM, Pertz O, Payrastre B, Gaits-Iacovoni F. 2014.
Phosphatidylinositol 5-phosphate regulates invasion through binding and
activation of Tiam1. Nat Commun 5:4080. http://dx.doi.org/10.1038/
ncomms5080.
68. Labrec EH, Schneider H, Magnani TJ, Formal SB. 1964. Epithelial cell
penetration as an essential step in the pathogenesis of bacillary dysentery.
J. Bacteriol. 88:1503–1518.
IpgD Activation of ARF6 in Shigella ﬂexneri Entry
March/April 2015 Volume 6 Issue 2 e02584-14 ® mbio.asm.org 11
69. Isberg RR, Falkow S. 1985. A single genetic locus encoded by Yersinia
pseudotuberculosis permits invasion of cultured animal cells by Escherichia
coli K-12. Nature 317:262–264. http://dx.doi.org/10.1038/317262a0.
70. Parsot C, Ménard R, Gounon P, Sansonetti PJ. 1995. Enhanced secretion
through the Shigella flexneri Mxi-Spa translocon leads to assembly of ex-
tracellular proteins into macromolecular structures. Mol Microbiol 16:
291–300. http://dx.doi.org/10.1111/j.1365-2958.1995.tb02301.x.
71. Marquart ME, Picking WL, Picking WD. 1996. Soluble invasion plasmid
antigen C (IpaC) from Shigella flexneri elicits epithelial cell responses re-
lated to pathogen invasion. Infect Immun 64:4182–4187.
72. Labigne-Roussel AF, Lark D, Schoolnik G, Falkow S. 1984. Cloning and
expression of an afimbrial adhesin (AFA-I) responsible for P blood group-
independent, mannose-resistant hemagglutination from a pyelonephritic
Escherichia coli strain. Infect Immun 46:251–259.
Garza-Mayers et al.
12 ® mbio.asm.org March/April 2015 Volume 6 Issue 2 e02584-14
